Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS

Barranquilla 080002

0 studies enrolling now · 4 studies all time

What they study most

Lupus Erythematosus, Systemic, Primary Sjogrens Disease, Rheumatoid Arthritis, Systemic Lupus Erythematosus

Studies at this site

• A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome — Running, not enrolling
• A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus — Completed
• An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus — Stopped early
• A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy — Stopped early